646 related articles for article (PubMed ID: 1279247)
1. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis-C virus and hepatoma].
Zala G; Havelka J; Altorfer J; Joller-Jemelka HJ; Risti B; Meier B; Schmid M; Bühler H
Schweiz Med Wochenschr; 1992 Feb; 122(6):194-7. PubMed ID: 1311125
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
7. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
8. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
9. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
12. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
[TBL] [Abstract][Full Text] [Related]
13. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T
Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790
[TBL] [Abstract][Full Text] [Related]
15. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease.
Takase S; Tsutsumi M; Kawahara H; Takada N; Takada A
Hepatology; 1993 Jan; 17(1):9-13. PubMed ID: 7678578
[TBL] [Abstract][Full Text] [Related]
16. [Type C hepatitis and hepatocellular carcinoma].
Kobayashi K
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1947-52. PubMed ID: 1329669
[TBL] [Abstract][Full Text] [Related]
17. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.
Caselmann WH; Alt M
J Hepatol; 1996; 24(2 Suppl):61-6. PubMed ID: 8836891
[TBL] [Abstract][Full Text] [Related]
19. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
20. [Breakthrough in human hepatocellular carcinogenesis--from hepatitis B virus to hepatitis C virus].
Nishioka K
Gan To Kagaku Ryoho; 1991 Mar; 18(3):327-36. PubMed ID: 1848417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
